Conclusion

Hypertensive disorders in pregnancy, particularly severe gestational hypertension and preeclampsia, pose significant risks to both mother and fetus. As emergent obstetric resources across the United States become more limited, the ED plays a critical role in improving maternal and fetal outcomes for both pregnant and recently pregnant patients in early detection, close monitoring, and timely treatment.

Dr. Solnick is an assistant professor in emergency medicine and research faculty at the Icahn School of Medicine at Mount Sinai in New York City.

Ms. Allison Warren is completing her final year as an honors undergraduate student at Yeshiva University majoring in biology and minoring in chemistry.

References

1. Cífková R. Hypertension in pregnancy: A diagnostic and therapeutic overview. High Blood Press Cardiovasc Prev. 2023;30(4):289-303.
2. The American College of Obstetricians and Gynecologists. Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Study. Reaffirmed March 2024. Accessed November 30, 2024.
3. Mihu D, Costin N, Mihu CM, et al. HELLP syndrome a multisystemic disorder. J Gastrointestin Liver Dis. 2007;16(4):419-424.
4. The American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2019;133(2):e174-e180.
5. Garovic VD, Dechend R, Easterling T, et al. Hypertension in pregnancy: Diagnosis, blood pressure goals, and pharmacotherapy: A scientific statement from the American heart association. Hypertension. 2022;79(2):e21-e41.
6. The American College of Obstetricians and Gynecologists and Safe Motherhood Initiative. Checklist: Hypertensive Emergency [Internet]. Revised January 2019. Accessed January 5, 2025.
7. The American College of Obstetricians and Gynecologists. Obstetric Emergencies in Nonobstetric Settings: Acute Hypertension in Pregnancy and Postpartum Algorithm. Accessed November 30, 2024.
8. Lydakis C, Lip GY, Beevers M, et al. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens. 1999;12(6):541-547.
9. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443-2451.
10. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-192.